Cargando…

Suppressing ERK Pathway Impairs Glycochenodeoxycholate-Mediated Survival and Drug-Resistance in Hepatocellular Carcinoma Cells

Glycochenodeoxycholate (GCDA), a toxic component in bile salts, is involved in carcinogenesis of gastrointestinal tumors. The objective of this research was to study the function of ERK1/2 in the GCDA-mediated survival and drug-resistance in hepatocellular carcinoma cells (HCCs). Firstly, extracellu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bingxin, Zhou, Maojun, Wang, Jue, Xu, Hongjuan, Yang, Manyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313996/ https://www.ncbi.nlm.nih.gov/pubmed/34327135 http://dx.doi.org/10.3389/fonc.2021.663944

Ejemplares similares

Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis
por: Hohenester, Simon, et al.
Publicado: (2020)

Glycochenodeoxycholic acid induces stemness and chemoresistance via the STAT3 signaling pathway in hepatocellular carcinoma cells
por: Shi, Changying, et al.
Publicado: (2020)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

Glycochenodeoxycholate Affects Iron Homeostasis via Up-Regulating Hepcidin Expression
por: Wang, Long-jiao, et al.
Publicado: (2022)

Vitexin ameliorates glycochenodeoxycholate-induced hepatocyte injury through SIRT6 and JAK2/STAT3 pathways
por: Zhang, Chuang, et al.
Publicado: (2021)

Sirt6 opposes glycochenodeoxycholate-induced apoptosis of biliary epithelial cells through the AMPK/PGC-1α pathway
por: Li, Jiye, et al.
Publicado: (2020)

CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways
por: Wu, Qiong, et al.
Publicado: (2021)

GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma
por: Qiu, Yu-an, et al.
Publicado: (2021)

Quantifying Serum Level of Glycochenodeoxycholic Acid Using High Performance Liquid Chromatography in Obstructive Jaundice Patients
por: Lalisang, Toar J. M., et al.
Publicado: (2012)

The utility of endogenous glycochenodeoxycholate-3-sulfate and 4β-hydroxycholesterol to evaluate the hepatic disposition of atorvastatin in rats
por: Ma, Yanrong, et al.
Publicado: (2021)

SPARC Negatively Correlates With Prognosis After Transarterial Chemoembolization and Facilitates Proliferation and Metastasis of Hepatocellular Carcinoma via ERK/MMP Signaling Pathways
por: Liu, Yao, et al.
Publicado: (2020)

Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis
por: Yan, Zilong, et al.
Publicado: (2022)

AnnexinA5 Might Suppress the Phenotype of Human Gastric Cancer Cells via ERK Pathway
por: Wang, Xiaojie, et al.
Publicado: (2021)

Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells via ERK/JNK Pathway
por: Cheng, Jianghong, et al.
Publicado: (2021)

Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway
Publicado: (2023)

PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway
por: Yan, Hongzhu, et al.
Publicado: (2020)

Niclosamide Inhibits Cell Growth and Enhances Drug Sensitivity of Hepatocellular Carcinoma Cells via STAT3 Signaling Pathway
por: Wang, Chengzhi, et al.
Publicado: (2018)

Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
por: Nandi, Deeptashree, et al.
Publicado: (2021)

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway
por: Song, Ye, et al.
Publicado: (2021)

Inhibition of HMGB1 Suppresses Hepatocellular Carcinoma Progression via HIPK2-Mediated Autophagic Degradation of ZEB1
por: Zhu, Wei, et al.
Publicado: (2021)

Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma
por: Himmelsbach, Vera, et al.
Publicado: (2021)

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
por: Moon, Hyuk, et al.
Publicado: (2021)

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway
por: Hu, Jiejun, et al.
Publicado: (2021)

Inhibition of RFX6 Suppresses the Invasive Ability of Tumor Cells Through the Notch Pathway and Affects Tumor Immunity in Hepatocellular Carcinoma
por: Song, Mu, et al.
Publicado: (2021)

Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
por: Chen, Qinjunjie, et al.
Publicado: (2020)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Identification of Glycochenodeoxycholate 3‐O‐Glucuronide and Glycodeoxycholate 3‐O‐Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers
por: Neuvonen, Mikko, et al.
Publicado: (2020)

Rapamycin inhibits oral cancer cell growth by promoting oxidative stress and suppressing ERK1/2, NF-κB and beta-catenin pathways
por: Semlali, Abdelhabib, et al.
Publicado: (2022)

Mediator Complex Subunit 19 Promotes the Development of Hepatocellular Carcinoma by Regulating the AKT/mTOR Signaling Pathway
por: Zhang, Yuting, et al.
Publicado: (2022)

Circular RNA Protein Tyrosine Kinase 2 Promotes Cell Proliferation, Migration and Suppresses Apoptosis via Activating MicroRNA-638 Mediated MEK/ERK, WNT/β-Catenin Signaling Pathways in Multiple Myeloma
por: Zhou, Fan, et al.
Publicado: (2021)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
por: Soria, Anna, et al.
Publicado: (2022)

Metabolic syndrome and survival of patients with hepatocellular carcinoma: A meta-analysis
por: Fu, Jia, et al.
Publicado: (2023)

Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
por: Kowalik, Marta Anna, et al.
Publicado: (2017)

UNC13C Suppress Tumor Progression via Inhibiting EMT Pathway and Improves Survival in Oral Squamous Cell Carcinoma
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2019)

Mutant NPM1-Regulated FTO-Mediated m(6)A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis
por: Xiao, Qiaoling, et al.
Publicado: (2022)

Propofol suppresses hepatocellular carcinoma by inhibiting NET1 through downregulating ERK/VEGF signaling pathway
por: Fei, Guoxiong, et al.
Publicado: (2020)

Refusal of Cancer-Directed Surgery Strongly Impairs Survival of Patients with Localized Hepatocellular Carcinoma
por: Wang, Jue, et al.
Publicado: (2010)

SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation
por: Song, Yunda, et al.
Publicado: (2020)

Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
por: Li, Hu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jo7jjacbu5is7ge4sbnd96uts4